Exicure, Inc. has announced that it will not be able to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, within the prescribed time period. The delay is due to the company finalizing certain accounting treatments and completing necessary reviews. This includes the restatement of its financial statements for the first and second quarters of 2023, as well as completing and filing the related Form 10-Q amendments and its third quarter financial statements. Consequently, Exicure does not expect to meet the original filing deadline for the Annual Report. The company has also not yet filed its Form 10-Q for the third quarter of 2023. Exicure anticipates a significant change in its results of operations compared to the previous...Show More

Exicure, Inc. has announced that it will not be able to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, within the prescribed time period. The delay is due to the company finalizing certain accounting treatments and completing necessary reviews. This includes the restatement of its financial statements for the first and second quarters of 2023, as well as completing and filing the related Form 10-Q amendments and its third quarter financial statements. Consequently, Exicure does not expect to meet the original filing deadline for the Annual Report. The company has also not yet filed its Form 10-Q for the third quarter of 2023. Exicure anticipates a significant change in its results of operations compared to the previous fiscal year, which will be reflected in the earnings statements. This change is attributed to a major reduction in workforce, suspension of preclinical activities, and cessation of all research and development activities announced in September 2022, as the company explores strategic alternatives. While research and development expenses have substantially decreased, general and administrative expenses are expected to be higher than the previous year. The notification was signed by Paul Kang, Chief Executive Officer, on April 1, 2024.